Literature DB >> 26901143

4E-BP1, a multifactor regulated multifunctional protein.

Xiaoyu Qin1, Bin Jiang1, Yanjie Zhang1.   

Abstract

Eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1) is a member of a family of translation repressor proteins, and a well-known substrate of mechanistic target of rapamycin (mTOR) signaling pathway. Phosphorylation of 4E-BP1 causes its release from eIF4E to allow cap-dependent translation to proceed. Recently, 4E-BP1 was shown to be phosphorylated by other kinases besides mTOR, and overexpression of 4E-BP1 was found in different human carcinomas. In this review, we summarize the novel findings on mTOR independent 4E-BP1 phosphorylation in carcinomas. The implications of overexpression and possible multi-function of 4E-BP1 are also discussed.

Entities:  

Keywords:  cancer; eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1; kinase; mTOR; overexpression; phosphorylation

Mesh:

Substances:

Year:  2016        PMID: 26901143      PMCID: PMC4845917          DOI: 10.1080/15384101.2016.1151581

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  52 in total

1.  Dissociation of the eukaryotic initiation factor-4E/4E-BP1 complex involves phosphorylation of 4E-BP1 by an mTOR-associated kinase.

Authors:  K J Heesom; R M Denton
Journal:  FEBS Lett       Date:  1999-09-03       Impact factor: 4.124

2.  Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases.

Authors:  A M Musti; M Treier; D Bohmann
Journal:  Science       Date:  1997-01-17       Impact factor: 47.728

3.  Mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation stabilizes ISCU protein: implications for iron metabolism.

Authors:  Ping La; Guang Yang; Phyllis A Dennery
Journal:  J Biol Chem       Date:  2013-03-18       Impact factor: 5.157

4.  mTOR-independent 4E-BP1 phosphorylation is associated with cancer resistance to mTOR kinase inhibitors.

Authors:  Yanjie Zhang; X F Steven Zheng
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

5.  Dephosphorylation of specific sites in the kinase-specificity sequence domain leads to ubiquitin-mediated degradation of the tyrosine phosphatase STEP.

Authors:  Saibal Mukherjee; Ranjana Poddar; Ishani Deb; Surojit Paul
Journal:  Biochem J       Date:  2011-11-15       Impact factor: 3.857

6.  Phosphorylation of 4E-BP1 is mediated by the p38/MSK1 pathway in response to UVB irradiation.

Authors:  Guangming Liu; Yiguo Zhang; Ann M Bode; Wei-Ya Ma; Zigang Dong
Journal:  J Biol Chem       Date:  2002-01-02       Impact factor: 5.157

7.  The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells.

Authors:  J Asano; A Nakano; A Oda; H Amou; M Hiasa; K Takeuchi; H Miki; S Nakamura; T Harada; S Fujii; K Kagawa; I Endo; K Yata; A Sakai; S Ozaki; T Matsumoto; M Abe
Journal:  Leukemia       Date:  2011-04-08       Impact factor: 11.528

8.  Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.

Authors:  Cherie-Ann O Nathan; Nazanin Amirghahari; Fleurette Abreo; Xiaohua Rong; Gloria Caldito; M Lamar Jones; Huijuan Zhou; Melanie Smith; Donnellan Kimberly; Jonathan Glass
Journal:  Clin Cancer Res       Date:  2004-09-01       Impact factor: 12.531

9.  Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila.

Authors:  Yuzuru Imai; Stephan Gehrke; Hua-Qin Wang; Ryosuke Takahashi; Kazuko Hasegawa; Etsuro Oota; Bingwei Lu
Journal:  EMBO J       Date:  2008-08-14       Impact factor: 11.598

10.  The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials.

Authors:  Elin Karlsson; Gizeh Pérez-Tenorio; Risul Amin; Josefine Bostner; Lambert Skoog; Tommy Fornander; Dennis C Sgroi; Bo Nordenskjöld; Anna-Lotta Hallbeck; Olle Stål
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466

View more
  92 in total

1.  Mammalian cell growth dynamics in mitosis.

Authors:  Teemu P Miettinen; Joon Ho Kang; Lucy F Yang; Scott R Manalis
Journal:  Elife       Date:  2019-05-07       Impact factor: 8.140

2.  Paracaspase MALT1 regulates glioma cell survival by controlling endo-lysosome homeostasis.

Authors:  Kathryn A Jacobs; Gwennan André-Grégoire; Clément Maghe; An Thys; Ying Li; Elizabeth Harford-Wright; Kilian Trillet; Tiphaine Douanne; Carolina Alves Nicolau; Jean-Sébastien Frénel; Nicolas Bidère; Julie Gavard
Journal:  EMBO J       Date:  2019-11-27       Impact factor: 11.598

3.  A Conditionally Fluorescent Peptide Reporter of Secondary Structure Modulation.

Authors:  Oleta T Johnson; Tanpreet Kaur; Amanda L Garner
Journal:  Chembiochem       Date:  2018-10-17       Impact factor: 3.164

4.  DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis.

Authors:  Pedro Barroso-Chinea; Diego Luis-Ravelo; Felipe Fumagallo-Reading; Javier Castro-Hernandez; Josmar Salas-Hernandez; Julia Rodriguez-Nuñez; Alejandro Febles-Casquero; Ignacio Cruz-Muros; Domingo Afonso-Oramas; Pedro Abreu-Gonzalez; Rosario Moratalla; Mark J Millan; Tomas Gonzalez-Hernandez
Journal:  Autophagy       Date:  2019-10-02       Impact factor: 16.016

5.  Yin and yang of 4E-BP1 in cancer.

Authors:  Ren Wang; Shridar Ganesan; X F Steven Zheng
Journal:  Cell Cycle       Date:  2016-04-20       Impact factor: 4.534

6.  The consequences of increased 4E-BP1 in polycystic kidney disease.

Authors:  Sara J Holditch; Carolyn N Brown; Daniel J Atwood; Deepak Pokhrel; Sara E Brown; Andrew M Lombardi; Khoa N Nguyen; Ryan C Hill; Miguel Lanaspa; Katharina Hopp; Mary C M Weiser-Evans; Charles L Edelstein
Journal:  Hum Mol Genet       Date:  2019-12-15       Impact factor: 6.150

Review 7.  PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer.

Authors:  Sabina Luszczak; Christopher Kumar; Vignesh Krishna Sathyadevan; Benjamin S Simpson; Kathy A Gately; Hayley C Whitaker; Susan Heavey
Journal:  Signal Transduct Target Ther       Date:  2020-01-31

8.  Expression of upstream and downstream targets of mTOR pathway in seven cases of secretory carcinoma of salivary gland origin.

Authors:  Marcos Custódio; Bruno Tavares Sedassari; Albina Altemani; Maria Fernanda Setúbal Destro Rodrigues; Fábio Daumas Nunes; Suzana Cantanhede Orsini Machado de Sousa
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-06-23       Impact factor: 2.503

9.  mTORC1/2 and Protein Translation Regulate Levels of CHK1 and the Sensitivity to CHK1 Inhibitors in Ewing Sarcoma Cells.

Authors:  Stacia L Koppenhafer; Kelli L Goss; William W Terry; David J Gordon
Journal:  Mol Cancer Ther       Date:  2018-10-03       Impact factor: 6.261

10.  Eukaryotic initiation factor 4E is a novel effector of mTORC1 signaling pathway in cross talk with Mnk1.

Authors:  Asiya Batool; Sheikh Tahir Majeed; Sabreena Aashaq; Rabiya Majeed; Nadiem Nazir Bhat; Khurshid Iqbal Andrabi
Journal:  Mol Cell Biochem       Date:  2019-11-28       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.